bcbs not covering glp 1 Blue Cross Blue Shield of Massachusetts will stop popular GLP-1 weight-loss drugs like Ozempic and Wegovy starting January 1, 2026. The decision comes as the costs for these medications have blue cross blue shield illinois

The battle over America's booming weight-loss drug market has a significant update, with a move thats likely to cause a shift across the healthcare and corporate benefits landscape: Cigna, one of Americas biggest insurers, is dropping coverage for GLP-1 obesity drugs, even for its own staff

Supplement manufacturers have capitalized on the explosive popularity of diabetes control and weight loss drugs such as Ozempic, Wegovy and Zepbound by flooding the market with their own pills,...

Theyre winning the battle of the bulge and losing the war on wrinkles.

So I decided to diversify

More fat burn

But emerging research suggests amylin agonists might become the next big thing.